The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

April 1998

Volume 38, Issue 4

Pages i–ii, 295–392

  1. Information for Authors

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Drug Development
    5. Pharmacokinetic Methods
    6. Drug Metabolism
    7. Psychopharmacology
    8. Pharmacokinetics and Pharmacodynamics
    9. Clinical Trials
    10. Departments
    1. INFORMATION FOR AUTHORS (pages i–ii)

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04427.x

  2. Therapeutic Review

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Drug Development
    5. Pharmacokinetic Methods
    6. Drug Metabolism
    7. Psychopharmacology
    8. Pharmacokinetics and Pharmacodynamics
    9. Clinical Trials
    10. Departments
    1. Innovative Drug Treatments for Viral and Autoimmune Myocarditis (pages 295–308)

      Dr. Sharmila Anandasabapathy and Dr. William H. Frishman

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04428.x

  3. Drug Development

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Drug Development
    5. Pharmacokinetic Methods
    6. Drug Metabolism
    7. Psychopharmacology
    8. Pharmacokinetics and Pharmacodynamics
    9. Clinical Trials
    10. Departments
    1. Performance of Human Mass Balance Studies with Stable Isotope-Labeled Drug and Continuous Flow-Isotope Ratio Mass Spectrometry: A Progress Report (pages 309–314)

      Dr. Thomas R. Browne, Mr. George K. Szabo, Dr. Alfred Ajami and Mr. David G. Browne

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04429.x

    2. Application of Population Pharmacokinetics to the Phase II Development of an Anti-Alzheimer's Disease Compound, S12024 (pages 315–323)

      C. Laveille, V. Lachaud-Pettiti, E. Neuman and R. Jochemsen

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04430.x

  4. Pharmacokinetic Methods

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Drug Development
    5. Pharmacokinetic Methods
    6. Drug Metabolism
    7. Psychopharmacology
    8. Pharmacokinetics and Pharmacodynamics
    9. Clinical Trials
    10. Departments
  5. Drug Metabolism

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Drug Development
    5. Pharmacokinetic Methods
    6. Drug Metabolism
    7. Psychopharmacology
    8. Pharmacokinetics and Pharmacodynamics
    9. Clinical Trials
    10. Departments
  6. Psychopharmacology

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Drug Development
    5. Pharmacokinetic Methods
    6. Drug Metabolism
    7. Psychopharmacology
    8. Pharmacokinetics and Pharmacodynamics
    9. Clinical Trials
    10. Departments
    1. Do Alprazolam-Induced Changes in Saccadic Eye Movement and Psychomotor Function Follow the Same Time Course? (pages 337–346)

      Dr. Patricia D. Kroboth, Ms. M. Margaret Folan, Dr. Kenneth S. Bauer, Dr. William Tullock, Dr. C. Eugene Wright and Dr. John A. Sweeney

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04433.x

  7. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Drug Development
    5. Pharmacokinetic Methods
    6. Drug Metabolism
    7. Psychopharmacology
    8. Pharmacokinetics and Pharmacodynamics
    9. Clinical Trials
    10. Departments
    1. Pharmacokinetics and Pharmacodynamics of Irbesartan in Patients with Hepatic Cirrhosis (pages 347–356)

      Dr. Maria R. Marino, Ms. Kathleen M. Langenbacher, Mr. Ralph H. Raymond, Dr. Neville F. Ford and Dr. Kenneth C. Lasseter

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04434.x

    2. A Phase I/II Evaluation of Oral L-2-Oxothiazolidine-4-Carboxylic Acid in Asymptomatic Patients Infected with Human Immunodeficiency Virus (pages 357–363)

      Dr. Patricia Barditch-Crovo, Dr. Dennis Noe, Dr. Gail Skowron, Dr. Michael Lederman, Dr. Robert C. Kalayjian, Dr. Peggy Borum, Ms. Rose Buier, Dr. W. Bruce Rowe, Dr. Dennis Goldberg and Dr. Paul Lietman

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04435.x

    3. Inhibition of Capsaicin-Induced Cough by the γ-Aminobutyric Acid Agonist Baclofen (pages 364–367)

      Peter V. Dicpinigaitis, Jay B. Dobkin, Khalid Rauf and Thomas K. Aldrich

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04436.x

    4. Evaluating the Safety of Calcipotriene 30 g Per Day in Patients with Psoriasis: A Parallel Group, Vehicle-Controlled Study (pages 368–372)

      Dr. Robert Blum, Dr. Edmund Schwartzel, Dr. Stewart Siskin and Dr. Warren W. Epinette

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04437.x

    5. KA 672-HCl, a Neuronal Activator Against Dementia: Tolerability, Safety, and Preliminary Pharmacokinetics after Single and Multiple Oral Doses in Healthy Male and Female Volunteers (pages 373–381)

      Dr. Hildegard Sourgens, Dr. Robert Hoerr, Dr. Anton Biber, Dr. Heike Steinbrede and Dr. Hartmut Derendorf

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04438.x

  8. Clinical Trials

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Drug Development
    5. Pharmacokinetic Methods
    6. Drug Metabolism
    7. Psychopharmacology
    8. Pharmacokinetics and Pharmacodynamics
    9. Clinical Trials
    10. Departments
    1. Brompheniramine, Loratadine, and Placebo in Allergic Rhinitis: A Placebo-Controlled Comparative Clinical Trial (pages 382–389)

      Dr. Howard M. Druce, Mr. William R. Thoden, Ms. Patti Mure, Dr. Sandy A. Furey, Dr. Earle A. Lockhart, Dr. Tailiang Xie, Dr. Stanley Galant, Dr. Bruce M. Prenner, Dr. Steven Weinstein, Dr. Robert Ziering and Dr. Milan L. Brandon

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04439.x

  9. Departments

    1. Top of page
    2. Information for Authors
    3. Therapeutic Review
    4. Drug Development
    5. Pharmacokinetic Methods
    6. Drug Metabolism
    7. Psychopharmacology
    8. Pharmacokinetics and Pharmacodynamics
    9. Clinical Trials
    10. Departments
    1. ACCP Announcements (pages 390–392)

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1998.tb04440.x

SEARCH

SEARCH BY CITATION